Skip to content

Clinical investigation of Topaz hair strengthening solution in preventing and improving hair loss

Clinical investigation of the safety and effectiveness of Topaz hair strengthening solution in preventing and improving male pattern androgenic hair loss

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210130050179N5
Enrollment
20
Registered
2022-11-26
Start date
2022-12-22
Completion date
Unknown
Last updated
2023-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hair loss. Nonscarring hair loss, unspecified

Interventions

Intervention group: Topically use of topaz hair strengthening solution
Includes: octapeptide 2, caffeine, B vitamins, amino acids, zinc and herbal extracts (Ginseng, Arctium, etc.) twice in a day for 12 weeks..

Sponsors

Qeshm Rojin Company
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Male aged 18-50 years General health Hair Loss Status II, III, IV Based on Norwood Scale Voluntary participation and signing written informed consent

Exclusion criteria

Exclusion criteria: Chronic active scalp disease other than hair loss Using any prescribed drug or OTC for hair loss within the past 3 months Documented sensitivity to formulation components Any severe weight loss or strict diet therapy during the study

Design outcomes

Primary

MeasureTime frame
Hair lost Changes, based on Global photographic review. Timepoint: Before intervention, 6 and 12 weeks after the start of use. Method of measurement: One independent dermatologist will perform clinical assessments in a blinded fashion by scoring every photograph according to the "Global photographic review" scale .

Secondary

MeasureTime frame
Hair count changes. Timepoint: Before intervention, 6 and 12 weeks after the start of use. Method of measurement: Trichoscopy By Fotofinder device.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactTaraneh Yazdanparast

Tehran University of Medical Sciences

drtaraneh@yahoo.com+98 21 8897 2220

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026